Cytokine Gene Polymorphisms in Primary Glaucoma: Insights into Inflammatory Pathways and Future Directions

Area of Science:

• Ophthalmology
• Neuroscience
• Genetics

Background:

• Glaucoma is a leading cause of irreversible blindness globally.
• Disease progression occurs even with controlled intraocular pressure (IOP), suggesting other pathogenic factors.
• Neuroinflammation involving glial cells and cytokines is implicated in retinal ganglion cell (RGC) apoptosis.

Purpose of the Study:

• To critically assess genetic associations between cytokine gene variants and primary glaucoma susceptibility.
• To explore mechanistic links between cytokine gene variants, glial activation, and ocular inflammation.
• To discuss the potential role of epigenetic modifications in glaucoma pathogenesis.

Main Methods:

• Systematic review and critical comparison of existing genetic association studies.
• Analysis of potential mechanisms linking genetic variations to glial activation and inflammatory responses.
• Discussion of limitations in current research and future directions.

Main Results:

• Inconsistencies and population-specific variability exist in reported associations between cytokine gene variants and glaucoma.
• A mechanistic gap remains in understanding how cytokine gene variants influence glial activation and the ocular inflammatory environment.
• Oxidative stress-mediated epigenetic modifications may amplify inflammatory responses in genetically predisposed individuals.

Conclusions:

• Genetic factors, particularly cytokine gene variants, may contribute to glaucoma pathogenesis beyond IOP.
• Further research is required to elucidate the complex interplay between genetics, neuroinflammation, and epigenetics in glaucoma.
• Understanding these mechanisms could lead to novel therapeutic strategies for glaucoma patients who progress despite IOP control.